Cancer Markers and Liquid Biopsies 2015

The role of cancer markers is significant towards the diagnosis, prognosis, and surveillance of a patient. Diagnostic screenings and early detection of cancer markers provide crucial information for better clinical application in managing and monitoring cancer. Understanding markers and characterizing circulating elements with the latest technologies aid our progress toward the future of better personalized cancer care.

Leaders in industry and academia will discuss platforms for isolating and studying CTCs. Technologies such as next generation sequencing and digital PCR are gaining momentum in these research areas. New perspectives in epigenetic plasticity and differentiation therapy will be shared in the CTC realm as well. They will also discuss biomarker sensitivity, stability, and validation, and how we can use markers to follow up with patients and improve the quality of life.